These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25742214)

  • 21. Family history of alcoholism and cognitive recovery in subacute withdrawal.
    Moriyama Y; Muramatsu T; Kato M; Mimura M; Kashima H
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):85-9. PubMed ID: 16472363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential neuroprotective effects of acamprosate.
    Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.
    De Witte P; Littleton J; Parot P; Koob G
    CNS Drugs; 2005; 19(6):517-37. PubMed ID: 15963001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acamprosate for alcohol dependence?
    Drug Ther Bull; 1997 Sep; 35(9):70-2. PubMed ID: 9350085
    [No Abstract]   [Full Text] [Related]  

  • 25. Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus.
    Mayer S; Harris BR; Gibson DA; Blanchard JA; Prendergast MA; Holley RC; Littleton J
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1468-78. PubMed ID: 12394279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients].
    Ladewig D; Knecht T; Leher P; Fendl A
    Ther Umsch; 1993 Mar; 50(3):182-8. PubMed ID: 8475472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
    Poldrugo F
    Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acamprosate.
    Drugs R D; 2002; 3(1):13-8. PubMed ID: 11881522
    [No Abstract]   [Full Text] [Related]  

  • 30. [Analysis of the EEG of alcoholic patients in the initial phase of abstinence].
    Frank H; Heber G; Fritsch M
    Nervenarzt; 1986 Dec; 57(12):730-5. PubMed ID: 3822021
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.
    Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
    Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alcohol misuse: with small steps to sobriety].
    Dtsch Med Wochenschr; 2013 Mar; 138(13):626-7. PubMed ID: 23512359
    [No Abstract]   [Full Text] [Related]  

  • 33. Lp(a) levels increase after ethanol withdrawal.
    Kervinen K; Savolainen MJ; Kesäniemi YA
    Alcohol Clin Exp Res; 1993 Aug; 17(4):926. PubMed ID: 8214436
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.
    Dahchour A; De Witte P
    Alcohol Clin Exp Res; 2003 Mar; 27(3):465-70. PubMed ID: 12658112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation.
    Hölter SM; Landgraf R; Zieglgänsberger W; Spanagel R
    Alcohol Clin Exp Res; 1997 Aug; 21(5):862-8. PubMed ID: 9267536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
    Kranzler HR; Gage A
    Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations on the management of alcohol withdrawal syndrome.
    Vasudeva R; Holt S
    J S C Med Assoc; 1990 Jan; 86(1):24-6. PubMed ID: 2308276
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacological relapse prevention in alcohol and tobacco dependence].
    Diehl A; Mann K
    Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological validation of a new animal model of alcoholism.
    Spanagel R; Hölter SM
    J Neural Transm (Vienna); 2000; 107(6):669-80. PubMed ID: 10943907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
    Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
    Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.